News

Mepolizumab significantly reduced the annualized rate of moderate or severe exacerbations in COPD with an eosinophilic ...
The impact of the global tariffs war will cost GE Healthcare Technologies Inc. around $500 million in 2025 at current rates, ...
Pfizer's CEO said President Donald Trump's tariffs and uncertainty are holding the company back from making "tremendous ...
The three stocks listed here below all pay more than a 3% dividend yield. Many stocks have been falling this year, and if you ...
Merck announced on Tuesday that it is investing $1 billion in a new Delaware plant to expand domestic production as it ...
We recently published a list of Billionaire Cliff Asness’ 10 Stock Picks with Huge Upside Potential. In this article, we are ...
Germany’s Merck KGaA has agreed to acquire U.S. biotech SpringWorks Therapeutics for $3.9 billion. The acquisition, aimed at ...
Merck & Co. Inc. managers escaped allegations that they hurt the pharmaceutical giant by misleading investors over traction ...
The pharmaceutical giant will invest $1 billion in a Delaware plant to manufacture Keytruda, as drugmakers ramp up U.S.
Merck & Co. will grow its U.S. manufacturing footprint with a $1 billion plant in Delaware, becoming the latest drugmaker to ...
MSD has begun construction on a $1bn biologics centre of excellence, Merck Wilmington Biotech, in the US state of Delaware.